Mo. ° / °
    Ariz. ° / °
    Calif. ° / °
ATSU Continuing Education

march, 2018

20mar(mar 20)5:30 pm21(mar 21)1:00 pmDO-Touch.NET Annual Meeting and Educational SeminarBreaking News: Is OMM Safe and Effective: Network’s Research Provides Insight


Event Details

Breaking News | Is OMM Safe and Effective?: Network’s Research Provides Insight

Dallas, Texas | Mar. 20-21, 2018

Click MORE for program information and tuition pricing.



*11 of AOA Category 1-A credits

  • Non-Members: $150 through Mar. 1, 2018
  • Non-Active DO-Touch.NET Members: $100 through Mar. 1, 2018
    * Those that have completed a membership form prior to January 1, 2018, but have not yet participated in a network study.
  • Active DO-Touch.NET Members: FREE through Mar. 1, 2018
    * Those that have recruited a participant into a network research study.
  • LATE: $200 Mar. 2-21, 2018

To become a member of DO-Touch.NET, CLICK HERE and join today!

Cancellation Policy

  • 21+ days prior to activity start date Full tuition refund less the $50 administrative fee
  • 14-21 days prior to activity start date 50% tuition refund less the $50 administrative fee
  • 1-14 days prior to activity start date No tuition refund


Mark your calendars and plan to attend!


CLICK HERE for the Program Brochure

CLICK HERE for the Program Schedule

Course Description
Want to know what the latest evidence on the use, effectiveness, and safety of osteopathic manipulative medicine is? Participants in this interactive course will have the first view of results from two recently completed DO-Touch.NET research studies and will engage in discussions about how these results can be interpreted. Additionally, participants will contribute to a consensus process for improving consistency when documenting osteopathic manipulative treatment techniques. Come join us in evaluating and advancing the practice of OMM!

Course Director
Brian Degenhardt, DO, C-NMM/OMM

Contact Information
For questions, contact Lisa Norman:
660.626.2443 or

Course Topics

  • Global PBRN – Transforming anecdotes into evidence
  • New evidence unexpected and provocative
  • PBRN overcoming challenges in OMM research
  • Research clinicians find excitement in everyday practice
  • Scientific revolution in OMM has begun. What is next?

*Program subject to change.

Educational Objectives

  • Explain the current status of the evidence for the effectiveness and safety of OMM
  • Recognize research opportunities in OMM
  • Categorize OMT techniques consistently based on definitions defined by the group

Target Audience
Osteopathic physicians and osteopaths who use osteopathic manipulative medicine in their clinical practice.

Professional Practice Gap
In an era of evidence-based medicine and new levels of research involving big data within the scientific community, it is critical to develop a culture of research within those osteopathic physicians who routinely perform osteopathic manipulation within their practice. To build such a culture, it is important to know what research has been done within osteopathic medicine, what is being done within the manual therapy research community and what is being prioritized for future research in this field. Based on this information, participants of the meeting/members of DO-Touch.NET will strategize the research direction for this network and strengthen the research culture within this PBRN.

Educational Need
Practitioners of OMT need to be informed about the strengths and weaknesses of research performed on OMT, what research is currently being performed within the field of osteopathic manual medicine and what is being prioritized by DO-Touch.NET for future research in this field. Practitioners of OMT also need to understand how they can participate in OMT research within their current practices and implement strategies to allow them and their office staff to participate in ongoing research in OMM. As a result, patients will receive better evidence-based practices and will be able to shape future research based on the responses to current interventions.

Desire Outcomes
Based on the educational objectives for this course, we expect participants to have expanded their knowledge-base about the use, effectiveness, and safety of osteopathic manipulative medicine. Additionally, we expect participants to be more mindful of how they document their use of osteopathic manipulative treatment techniques.

Accreditation Statement
ATSU is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ATSU designates this program for a maximum of 11 of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Call the ATSU CE Office at 660-626-2232 for more information.



Hilton Anatole Dallas
2201 N. Stemmons Freeway
Dallas, Texas 75207

For more information and to make reservations, go to

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.


20 (Tuesday) 5:30 pm - 21 (Wednesday) 1:00 pm CST


Hilton Anatole Dallas

2201 N. Stemmons Freeway, Dallas, Texas 75207


DO-Touch.NETSara Amini-Rad, MPH, CHES | 660.626.2101 |

Comments are closed.